Home | About IJMPO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Indian Journal of Medical and Paediatric Oncology
Search Article 
  
Advanced search 
 
COURTING CONTROVERSY
Year : 2020  |  Volume : 41  |  Issue : 4  |  Page : 587-590

Immunotherapy in nonsmall cell lung cancer (basket of choices)


Department of Medical Oncology, Fortis Memorial Research Institute, Gurugram, Haryana, India

Correspondence Address:
Dr. Abhishek Raj
Department of Medical Oncology, Fortis Memorial Research Institute, Sector 44, Gurugram - 122 002, Haryana
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijmpo.ijmpo_101_20

Rights and Permissions

The advent of immunotherapy has changed the landscape of lung cancer management over the past few years. Once a uniformly fatal disease with limited therapeutic options, the physicians now have a myriad of options to choose from while offering therapy to a patient of metastatic nonsmall cell lung cancer.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed226    
    Printed2    
    Emailed0    
    PDF Downloaded46    
    Comments [Add]    

Recommend this journal